Literature DB >> 1309183

Medications in older patients.

M Hobson1.   

Abstract

Adverse drug reactions are common in persons aged 65 and older and are associated with increased morbidity and mortality. A heightened susceptibility to adverse reactions is due to a number of factors, including an increased incidence of disease, multiple drug use, and altered pharmacokinetic and pharmacodynamic properties of many drugs. The risk of drug interactions increases with the number of medications taken. Adverse drug reactions can be prevented through prudent prescribing practices, patient education, and adequate monitoring of drug efficacy and side effects. Several types of medications are of particular concern, including many antihypertensive agents, drugs with anticholinergic effects, psychoactive medications, and nonsteroidal anti-inflammatory drugs. Some drugs, such as histamine H2-receptor antagonists, are relatively safe but are overprescribed. Data regarding the risks associated with these problem drugs are presented, with recommendations for safe and effective treatment alternatives.

Entities:  

Mesh:

Year:  1992        PMID: 1309183      PMCID: PMC1022033     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  35 in total

Review 1.  Cholesterol can be lowered in older persons. Should we care?

Authors:  F E Kaiser; J E Morley
Journal:  J Am Geriatr Soc       Date:  1990-01       Impact factor: 5.562

2.  Reduced beta-adrenoceptor sensitivity in the elderly.

Authors:  R E Vestal; A J Wood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

3.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

Authors:  J D Bradley; K D Brandt; B P Katz; L A Kalasinski; S I Ryan
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

Review 4.  Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature.

Authors:  P M Helms
Journal:  J Am Geriatr Soc       Date:  1985-03       Impact factor: 5.562

Review 5.  Altered pharmacodynamics in the elderly.

Authors:  J Feely; D Coakley
Journal:  Clin Geriatr Med       Date:  1990-05       Impact factor: 3.076

6.  Adverse drug reactions associated with global cognitive impairment in elderly persons.

Authors:  E B Larson; W A Kukull; D Buchner; B V Reifler
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

7.  Age-related risks of long-term oral anticoagulant therapy.

Authors:  J H Gurwitz; R J Goldberg; A Holden; N Knapic; J Ansell
Journal:  Arch Intern Med       Date:  1988-08

8.  Relationship between diazepam dose, plasma level, age, and central nervous system depression.

Authors:  M M Reidenberg; M Levy; H Warner; C B Coutinho; M A Schwartz; G Yu; J Cheripko
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

9.  Therapeutic effects of drug-nutrient interactions in the elderly.

Authors:  D A Roe
Journal:  J Am Diet Assoc       Date:  1985-02

Review 10.  Hypertension in elderly patients.

Authors:  W B Applegate
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

View more
  4 in total

1.  Reserpine and thiazide for hypertension--an inexpensive therapy for older patients.

Authors:  L Z Feigenbaum
Journal:  West J Med       Date:  1993-05

2.  Improving drug therapy in the elderly.

Authors:  R R Finley; A L Leeds
Journal:  West J Med       Date:  1993-10

3.  Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.

Authors:  D B Hogan; N R Campbell; R Crutcher; P Jennett; N MacLeod
Journal:  CMAJ       Date:  1994-08-01       Impact factor: 8.262

4.  Physician practicing preferences for conventional or homeopathic medicines in elderly subjects with musculoskeletal disorders in the EPI3-MSD cohort.

Authors:  Karine Danno; Clementine Joubert; Gerard Duru; Jean-Marie Vetel
Journal:  Clin Epidemiol       Date:  2014-09-26       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.